We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Tecan and Siloam Biosciences Market New ELISA System

By LabMedica International staff writers
Posted on 12 Sep 2012
Print article
Tecan (Mannedorf, Switzerland) and Siloam Biosciences Inc. (Cincinnati, OH, USA) announced their intent to comarket an automated, low volume, high sensitivity, microfluidic enzyme-linked immunosorbent assay (ELISA).

The system is based on Tecan’s Freedom EVO liquid handling technology and Siloam Biosciences’ OptiMax microplate. It offers rapid, sensitive, and specific chemifluorescence-based ELISA procedures using very small sample volumes. The automation-compatible OptiMax microplate is a new 96-well plate with a microfluidic channel at the base of each well that functions as a reaction chamber, taking advantage of the power of microfluidics to allow for low volume, rapid and sensitive immunoassay protocols.

The Freedom EVO automatically loads analytes and reagents into the wells of the microfluidic microplate, and allows the robotic manipulation of multiple OptiMax microplates. The microfluidic design of the Optimizer technology contributes to the speed, sensitivity, and small sample requirements. All reactions, including analyte capture and detection, occur within an approximately 5 μL microfluidic reaction chamber. The microchannel geometry and small reaction volume favor rapid reaction kinetics.

A typical assay requires only a 5 μL sample and each reaction step is completed within 10 to 20 minutes. With wash times, substrate incubations, and read times accounted for, a typical Optimizer technology-based ELISA can be completed within two hours. Rapid reaction kinetics on a microscale, coupled with microplate automation on the Freedom EVO workstation, allows for high sensitivity and fast assays.

Aniruddha Puntambekar, COO at Siloam Biosciences Inc., commented, “Tecan’s automation systems enhance the performance of OptiMax automation plates and we are pleased to be able to offer improvements to ELISA users based on Tecan’s automation expertise. Together, our technologies provide significant advances to immunoassay testing that will benefit customers of both companies.”

Related Links:
Tecan
Siloam Biosciences Inc.

Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
FLU/RSV Test
Humasis FLU/RSV Combo
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.